GTP Bioways

GTP Bioways Contract Manufacturing & Development (CDMO) Profile

GTP Bioways, a French CDMO with more than 20 years’ experience provides one-stop-shop services for biopharmaceutical clinical development. From late-stage discovery through preclinical and clinical trials to market readiness, we provide seamless support across the entire development spectrum—from initial process development to cGMP manufacturing, aseptic filling, and analytical development.

Our distinct advantage lies in our expertise in both mammalian and microbial expression systems, enabling us to manufacture a wide range of large molecules, including biologics and ADCs with highly potent payloads. We also take pride in our integrated fill & finish services for both small and large molecules.

At the core of our operations are our customer-centric values: empathy, integrity, and transparency. This commitment ensures that our clients achieve their development goals efficiently and effectively.

CDMO Services:
Biologics Drug Substance Manufacturing (API); Drug Product Formulation (FDF) Liquids; Pre-Filled Syringes (PFS); Sterile Vials Analytical Development; Cell Line Development; Formulation Development; Process Development; Protein Synthesis Antibodies; Antibody-drug conjugate (ADC); Fusion Proteins; Recombinants + other Proteins; Protein Vaccines

Year Founded: 2000

Head Office: Toulouse, France

Number of Facilities: 3-5

Facility locations: Europe

Website: Visit the GTP Bioways website

Linkedin: Connect on Linkedin

Current Capacity: up to 1000L in mammalian

up to 350L in microbial

up to 10,000 units in aseptic filling